JEVTANA J Code: J9043

Drug & Product Overview

HCPCS Descriptor Injection, cabazitaxel, 1 mg

HCPCS Added Date January 1, 2012

Manufacturer Sanofi

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Kit

About JEVTANA

Jevtana is a medication aligned to the HCPCS J Code: J9043 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Sanofi.

According to CMS Drug Use Information: Cabazitaxel is used to treat prostate cancer. It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00024-5824-11	Jevtana	Sanofi-Aventis U.S. LLC	60	Kit

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

JEVTANA Pricing & Reimbursement

J9043 Private Payer Reimbursement

$238.40 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Cabazitaxel 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9043	Sanofi	Cabazitaxel	Injection, cabazitaxel, 1 mg

JEVTANA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 20.66%

Avg. Days to File 12.5days

Avg. Days to Pay 28.2days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9043 claims analytics on FocalPoint →

JEVTANA CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Jevtana (J9043) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

JEVTANA Medically Unlikely Edits (MUE)

The most billing units of J9043 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

60 units / day

= 60 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

JEVTANA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

metastatic castration-resistant prostate cancer

Frequently Asked Questions

Is there an available Jevtana billing and coding guide?

Billing and coding information for JEVTANA can be found through Sanofi. Visit Here →

Are there any available Jevtana patient assistance programs?

JEVTANA patient assistance information can be found through Sanofi. Visit Here →

Where can I find Jevtana prescribing information?

JEVTANA prescribing information can be found at the link below: Visit Here →

Where can I find Jevtana side effect information?

Information regarding JEVTANA's side effects can be found at MedlinePlus Visit Here →

Does billing JEVTANA require JZ/JW wastage modifiers?

CMS has identified JEVTANA(J9043) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.